Li-Fraumenijev sindrom

  • Miroslav P. Ilić Clinic for Maxillofacial and Oral Surgery Clinical Centre of Vojvodina, Novi Sad, Serbia; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
  • Aleksandar Kiralj Clinic for Maxillofacial and Oral Surgery Clinical Centre of Vojvodina, Novi Sad, Serbia; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
  • Borislav Markov Clinic for Maxillofacial and Oral Surgery Clinical Centre of Vojvodina, Novi Sad, Serbia
  • Ivana Mijatov Clinic for Maxillofacial and Oral Surgery Clinical Centre of Vojvodina, Novi Sad, Serbia; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
  • Saša Mijatov Clinic for Maxillofacial and Oral Surgery Clinical Centre of Vojvodina, Novi Sad, Serbia; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
  • Nada Vučković Clinic for Maxillofacial and Oral Surgery Clinical Centre of Vojvodina, Novi Sad, Serbia; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Ključne reči: li-fraumeni syndrome||, ||li-fraumeni sindrom, diagnosis||, ||diagnosis, treatment outcome||, ||lečenje, ishod, prognosis||, ||prognoza,

Sažetak


Uvod. Li-Fraumenijev sindrom (LFS) predstavlja veoma retko familijarno obolenje sa predispozicijom za razvoj pojedinih malignih tumora, kao što su: osteosarkom, karcinom dojke, neoplazma mozga, leukemija i adrenalni tumori Nasleđuje se autozomno dominantno, a nastaje usled heterozigotne mutacije na genu p53. Dijagnoza se postavlja na osnovu kliničkih kriterijuma: osoba mlađa od 45 godina obolela od sarkoma, najbliži srodnik mlađi od 45 godina oboleo od karcinoma i srodnik prvog ili drugog kolena koji je do 45. godine oboleo od karcinoma ili oboleo od sarkoma u bilo kom uzrastu. Prikaz bolesnika. U radu je prikazana porodica u kojoj su kod tri ćlana dijagnostikovana maligna obolenja karakteristična za LFS. Muškarac star 24 godine oboleo i lečen od osteosarkoma gornje vilice preminuo je u toku prve godine. Njegov mlađi brat je 3 godine kasnije operisan od osteosarkoma donje vilice, a godinu dana kasnije u svojoj 24 godini bio je bez znakova lokoregionalnog recidiva. Njihova majka je 1996. godine operisana od multiformnog glioblastoma mozga i duktalnog karcinoma dojke. Umrla je dve godine kasnije u 33. godini života.  Zaključak. Ovaj prikaz ukazuje na potrebu pažljivog pregleda, kontrolisanja i obaveštavanja o rizicima članova porodice obolelih od tumora koji su u vezi sa LFS.

Reference

Hisada M, Garber JE, Fung CY, Fraumeni JF, Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 1998; 90(8): 606−11.

Lynch HT, Guirgis HA. Childhood cancer and the SBLA syn-drome. Med Hypotheses 1979; 5(1): 15−22.

Li FP, Fraumeni JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988; 48(18): 5358−62.

Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 1994; 54(5): 1298−304.

Bachinski LL, Olufemi S, Zhou X, Wu C, Yip L, Shete S, et al. Genetic mapping of a third Li-Fraumeni syndrome predisposition locus to human chromosome 1q23. Cancer Res 2005; 65(2): 427−31.

Malkin D. Li-Fraumeni syndrome. Genes Cancer 2011; 2(4): 475−84.

Li FP, Fraumeni JF. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome. Ann Intern Med 1969; 71(4): 747−52.

Li FP, Fraumeni JF. Prospective study of a family cancer syn-drome. JAMA 1982; 247(19): 2692−4.

Pearson AD, Craft AW, Ratcliffe JM, Birch JM, Morris-Jones P, Ro-berts DF. Two families with the Li-Fraumeni cancer family syndrome. J Med Genet 1982; 19(5): 362−5.

Hartley AL, Birch JM, Marsden HB, Harris M. Malignant mela-noma in families of children with osteosarcoma, chondrosar-coma, and adrenal cortical carcinoma. J Med Genet 1987; 24(11): 664−8.

Strong LC, Stine M, Norsted TL. Cancer in survivors of child-hood soft tissue sarcoma and their relatives. J Natl Cancer Inst 1987; 79(6): 1213−20.

Li FP, Fraumeni JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988; 48(18): 5358−62.

Masciari S, Dewanwala A, Stoffel EM, Lauwers GY, Zheng H, Achatz MI, et al. Gastric cancer in individuals with Li-Fraumeni syndrome. Genet Med 2011; 13(7): 651−7.

Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, et al. Beyond Li-Fraumeni syndrome: Clinical cha-racteristics of families with p53 germline mutations. J Clin On-col 2009; 27(8): 1250−6.

Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, et al. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 2003; 63(20): 6643−50.

Chompret A, Brugières L, Ronsin M, Gardes M, Dessarps-Freichey F, Abel A, et al. P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer 2000; 82(12): 1932−7.

Objavljeno
2015/04/24
Rubrika
Prikaz bolesnika